Dexcom Stock Analysis & Ratings
DXCM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$67.11 - $659.45
Previous Close$78.46
Volume2.81M
Average Volume (3M)3.54M
Market CapN/A
Enterprise ValueN/A
P/E Ratio151.6
Beta1.26
Next EarningsJul 28, 2022
EPS Forecast$0.19
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price Target$117.23
Smart Score9
Dexcom News
P/E Ratio Range
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DXCM FAQ
What was Dexcom’s price range in the past 12 months?
Dexcom lowest stock price was $67.11 and its highest was $659.45 in the past 12 months.
What is Dexcom’s market cap?
Currently, no data Available
What is Dexcom’s price target?
The average price target for Dexcom is $117.23. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $140.00 ,the lowest forecast is $87.00. The average price target represents 49.62% Increase from the current price of $78.35.
The highest analyst price target is $140.00 ,the lowest forecast is $87.00. The average price target represents 49.62% Increase from the current price of $78.35.
What do analysts say about Dexcom?
Dexcom’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
When is Dexcom’s upcoming earnings report date?
Dexcom’s upcoming earnings report date is Jul 28, 2022 which is in 21 days.
How were Dexcom’s earnings last quarter?
Dexcom released its earnings results on Apr 28, 2022. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.131 by -$0.051.
Is Dexcom overvalued?
According to Wall Street analysts Dexcom’s price is currently Undervalued.
Does Dexcom pay dividends?
Dexcom does not currently pay dividends.
What is Dexcom’s EPS estimate?
Dexcom’s EPS estimate is $0.19.
How many shares outstanding does Dexcom have?
Dexcom has 392,503,720 shares outstanding.
What happened to Dexcom’s price movement after its last earnings report?
Dexcom reported an EPS of $0.08 in its last earnings report, missing expectations of $0.131. Following the earnings report the stock price went down -1.133%.
Which hedge fund is a major shareholder of Dexcom?
Among the largest hedge funds holding Dexcom’s share is Sands Capital Management LLC. It holds Dexcom’s shares valued at 2B.
---
Dexcom Stock Analysis
Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Price Target
$117.23
Strong Buy▲(49.62% Upside)
Analyst Forecast
Strong Buy
Average Price Target: $117.23
Blogger Sentiment
Bullish
DXCM Sentiment 77% Sector Average 71%
Hedge Fund Holdings
▲ Increased
By 3.8M Shares Last Quarter.
Insider Transactions
N/A
Currently Not Enough Data Available
Retail Investors
Very Positive
Last 7 Days ▲ 0.2% Last 30 Days ▲ 5.3%
News Sentiment
Positive
Bullish 100% Bearish 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.28%
12-Months-Change
Fundamentals
Return on Equity
10.35%
Trailing 12-Months
Asset Growth
15.20%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Dexcom
California-based DexCom, Inc. is a medical device manufacturing company. The company designs, develops and focuses on commercialization of continuous glucose monitoring (CGM) systems for ambulatory use by people with diabetes. Its products include DexCom G4 PLATINUM System, DexCom G5 Mobil, DexCom G6, and DexCom Share.
---
Company
Price & Change
Follow
Johnson & Johnson
―
Senseonics Holdings
―
Roche Holding
―
Tandem Diabetes Care
―
Insulet
―
---